Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stock
-
Number of holders
-
31
-
Total shares
-
4.39M
-
Shares change
-
-193M
-
Total reported value, excl. options
-
$1.58M
-
Value change
-
-$173M
-
Number of buys
-
8
-
Number of sells
-
-178
-
Price
-
$0.36
Significant Holders of SORRENTO THERAPEUTICS INC - Common Stock (SRNE) as of Q1 2023
31 filings reported holding SRNE - SORRENTO THERAPEUTICS INC - Common Stock as of Q1 2023.
SORRENTO THERAPEUTICS INC - Common Stock (SRNE) has 31 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.39M shares
.
Largest 10 shareholders include Paloma Partners Management Co (3.78M shares), OAKTREE CAPITAL MANAGEMENT LP (134K shares), Oaktree Fund Advisors, LLC (66K shares), Crescent Grove Advisors, LLC (60K shares), Lattice Capital Management, LLC (51.8K shares), S&T Bank/PA (38.9K shares), GoalVest Advisory LLC (32.9K shares), Houlihan Financial Resource Group, Ltd. (30K shares), Valeo Financial Advisors, LLC (27.5K shares), and Granite Bay Wealth Management, LLC (22.5K shares).
This table shows the top 31 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.